Ukrainian Therapeutical Journal · Jun 30, 2026
Association between anthropometabolic indicators and telomere length in patients with systemic metabolic disorders
By Kolesnikova OV, Radchenko AO, Zaprovalna O
Objective — to determine anthropometric and anthropometa-bolic markers, as well as calculated indices, that can serve as indicators of telo-mere shortening in patients with systemic metabolic disorders (SMD), in whom metabolic dysfunction-associated steatotic liver disease (MASLD) represents a key clinical component. Materials and methods. The study included 324 patients with SMD (medi-an age 54.3 [49.5, 59.9] years, 69% men), all of whom had MASLD as a comor-bid condition. Depending on the telomere length (TL), patients were divided into two groups, comparable in age and sex: group 1 — with preserved TL (≥ 1.0, n=174) and group 2 — with shortened TL (< 1.0, n=150). The following indices were calculated for all patients: waist—to—hip ratio (WHR), waist-to-height ratio (WHtR), body mass index (BMI), triglyceride—glucose index (TyG), waist—triglyceride index (WTI), and combined indices of TyG‑waist circumference (WC), TyG‑WHtR, and TGI‑BMI. Results. Significant differences between groups were observed in the levels of direct bilirubin (p=0.001), glucose (p<0.001), low-density lipoprotein cho-lesterol (p=0.039), and TyG‑WC (p=0.020). Among the examined patients with SMD, the prevalence of cardiometabolic risk factors was 92% for over-weight/obesity (including abdominal), 37% for dysglycemia/diabetes mellitus (DM), 44% for elevated plasma triglycerides, 23% of patients had reduced high-density lipoprotein cholesterol levels, and 84% had arterial hypertension. The assessment of the prevalence of these factors in the groups revealed signifi-cant differences only for carbohydrate profile disorders (p<0.05): patients with dysglycemia (40% vs. 24%) and DM (8% vs. 3%), as well as disturbances in anthropometric status (96% vs. 88%) were more common in group 2. Although the differences were not significant, the distribution of patients depending on in-dividual anthropometric risk factors revealed a lower prevalence in group 2: re-garding BMI ≥ 30 kg/m2 — 42% vs. 58%, WC ≥ 94 cm for men and ≥ 80 cm for women — 48% vs. 52%, WHR ≥ 0.9 for men and ≥ 0.85 cm for women — 48% vs. 52%, WHtR ≥ 0.6 — 43% vs. 57%. In group 2, an inverse relationship was found between TL and WC (p<0.001), hip circumference (p<0.001), TyG‑WC (p<0.001). Conclusions. In patients with SMD, an increase in the TyG‑WC index can be considered as a potential indicator of TL shortening and the need for additional therapeutic approaches aimed at suppressing adverse epigenetic changes. Isolated anthropometric measures have limited diagnostic value for identifying individuals with SMD at risk of telomere shortening without considering metabolic context and dynamic changes.